Full Text
PEY16 COST-UTILITY ANALYSIS FOR PEGAPTANIB IN AGE-RELATED MACULAR DEGENERATION IN THE UK- THE IMPACT OF DEMOGRAPHIC AND DISEASE CHARACTERISTICS

Abstract

Authors

S Wolowacz N Roskell F Maciver S Kelly

Back to Volume 9, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×